Alzecure: Jan Lundberg proposed as board member - Redeye
Redeye endorses today’s news that the nomination committee has proposed Jan Lundberg, Eli Lilly's and AstraZeneca's former head of research, as a new board member of Alzecure. We give a short comment.
ANNONS
Redeye endorses today’s news that the nomination committee has proposed Jan Lundberg, Eli Lilly's and AstraZeneca's former head of research, as a new board member of Alzecure. We give a short comment.